Results 141 to 150 of about 578 (168)

Antihistamine Updosing Reduces Disease Activity in Patients With Difficult-to-Treat Cholinergic Urticaria [PDF]

Journal of Allergy and Clinical Immunology, 2016
Andreas Werner, Sabine Altrichter, Marcus Maurer   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Omalizumab Updosing Allows Disease Activity Control in Patients With Refractory Chronic Spontaneous Urticaria

British Journal of Dermatology, 2018
Ignasi Figueras-Nart, Xavier Cubiró, Laia Curto-Barredo   +2 more
exaly   +4 more sources

Efficacy and Safety of Omalizumab Updosing in Chronic Urticaria: A Retrospective Study.

Skinmed, 2023
Omalizumab is an effective and safe treatment option with licensed doses in patients with chronic spontaneous urticaria (CSU); however, some patients are not responsive to licensed doses and require updosing. As studies concerning updosing were insufficient, the present study evaluated the effectiveness and safety of omalizumab updosing (300 mg every 2
Fatma Asli, Hapa, Fatma Elif, Yıldırım   +1 more
openaire   +1 more source

Bilastine: a new H₁‐antihistamine with an optimal profile for updosing in urticaria

Journal of the European Academy of Dermatology and Venereology, 2017
AbstractThis review set out to examine published papers detailing the efficacy of bilastine in skin models and urticaria to assess whether it meets the optimal profile for updosing in urticaria, that is, strong clinical efficacy and freedom from unwanted side effects, particularly sedation.
M K, Church, L, Labeaga
openaire   +2 more sources

Updosing of Bilastine Is Effective in Moderate to Severe Chronic Spontaneous Urticaria: A Real-Life Study

Allergy: European Journal of Allergy and Clinical Immunology, 2018
Markus Magerl, Sabine Altrichter, Tomasz Hawro   +2 more
exaly   +3 more sources

Remote Oral Immunotherapy Updosing: Access, Safety, and Economics

Annals of Allergy, Asthma and Immunology
Richard L Wasserman
exaly   +2 more sources

Food Sublingual Immunotherapy: Safety and Simplicity of a Real Food Updosing Protocol

The Journal of Allergy and Clinical Immunology: In Practice
Sublingual immunotherapy (SLIT) using food extracts is safe and effective in desensitizing patients with food allergy, yet not often used in clinical practice.To propose a cost-effective, expedited SLIT protocol using real food.Patients with food allergy aged 5 to 50 years (median, 11 years) initiated food SLIT in a single-clinic setting.
Reed R, Windom, Samantha, Seitz, Jean B, Ly, Neha, Dunn, Jennifer, Fergeson, Hugh H, Windom   +5 more
openaire   +2 more sources

Fast Updosing of Subcutaneous House Dust Mite Immunotherapy Is Well Tolerated by Pediatric Patients [PDF]

International Journal of Immunology and Immunotherapy, 2016
exaly   +2 more sources

Efficacy and tolerability of the updosing of second‐generation non‐sedating H1 antihistamines in children with chronic spontaneous urticaria

Pediatric Allergy and Immunology, 2020
AbstractBackgroundChronic urticaria (CU), daily wheals or angioedema that lasts more than 6 weeks, is a common skin disease; CU is classified as spontaneous (no specific eliciting factor involved) or inducible (specific eliciting factor involved). Recent EAACI guidelines for management of CSU recommend second‐generation non‐sedating H1 antihistamines ...
Sarti, Lucrezia, Barni, Simona, Giovannini, Mattia, Liccioli, Giulia, Novembre, Elio, Mori, Francesca   +5 more
openaire   +2 more sources

Specific Oral Tolerance Induction With A Weekly Updosing Schedule In Children With Ige Mediated Cow's Milk Allergy

Journal of Allergy and Clinical Immunology, 2009
Abstract ...
PAJNO, Giovanni Bat., L. CAMINITI, S. BARBERI, D. VITA, C. E. BAENA CAGNANI, BARBERIO BARBERIO, Giovanni, RUGGERI, Paolo, G. PASSALACQUA   +7 more
openaire   +3 more sources